Coleman Glenn 4
4 · CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Filed May 4, 2026
Research Summary
AI-generated summary of this filing
Charles River (CRL) CFO Glenn Coleman Receives RSU Award
What Happened
Glenn Coleman, Chief Financial Officer of Charles River Laboratories (CRL), received an award of 21,112 restricted stock units (RSUs) on May 1, 2026. The award is reported at a per-share value of $165.78, for a total grant value of $3,499,947. This is a compensation grant (an acquisition/award), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-05-01; Form 4 filed: 2026-05-04 (no late filing indicated).
- Grant size and value: 21,112 RSUs @ $165.78 per share = $3,499,947 total.
- Vesting: Unvested RSUs vest ratably on May 1 of 2027, 2028, 2029 and 2030 (per footnote F1).
- Shares owned after the transaction: Not specified in the provided filing.
- Transaction type code: A (award/grant). No 10b5-1 plan, tax withholding, or cashless exercise noted in this filing.
Context
RSUs are a form of equity compensation that become actual shares only as they vest; this grant is primarily a compensation/retention action by the company rather than an outright insider market buy or sell. Such awards increase potential future insider ownership if and when they vest, but do not represent an immediate market purchase.
Insider Transaction Report
- Award
Common Stock
[F1]2026-05-01$165.78/sh+21,112$3,499,947→ 21,112 total
Footnotes (1)
- [F1]Unvested restricted stock units annually ratably vest on: May 1, 2027; May 1, 2028; May 1, 2029; and May 1, 2030.